Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,38118,400 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Defining the role of FAM83B in lung cancer using a new mouse model
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2021 – 2023

ABSTRACT RAS signaling is one of the most commonly altered oncogenic pathways in human cancer and one of the most targeted pathways in drug discovery programs.Yet, while numerous s...

$805K
USD
Completed NON-SBIR/STTR RPGS
A Simulation Modeling Study to Support Personalized Breast Cancer Prevention and Early Detection in High-Risk Women
NATIONAL CANCER INSTITUTE Georgetown University United States 2021 – 2023

Abstract: Personalized care is complex in this unprecedented era of discovery and ?big data?.The proposed study focuses on the real-world choices facing over 100,000 US women each...

$780K
USD
Completed NON-SBIR/STTR RPGS
A Preventive Care Approach to Mitigate the Impact of Pediatric ALL Treatment on Sleep
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2023

Project Summary Over 50% of pediatric cancer patients report problems with their sleep, characterized by insomnia disorder symptoms.This results in considerable physical and psycho...

$890K
USD
Completed NON-SBIR/STTR RPGS
Gene Expression Analysis of Dog Natural Killer Cells as Immunotherapy Target
NATIONAL CANCER INSTITUTE University of California At Davis United States 2021 – 2023

Project Summary Dogs are large, outbred animals that develop cancer spontaneously in the presence of an intact immune system and in the setting of shared environmental exposures wi...

$785K
USD
Completed NON-SBIR/STTR RPGS
Robot-Assisted Personalized Prostate Biopsy
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Prostate cancer (PCa) is the most commonly diagnosed type of cancer and the second leading cause of cancer related death among US men. The best current est...

$3.16M
USD
Completed NON-SBIR/STTR RPGS
Understanding the Guideline-Discordant Use of Bone Modifying Agents in Prostate Cancer
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2023

PROJECT SUMMARY Bone-modifying agents (BMAs) can improve quality-of-life in metastatic prostate cancer.The BMAs zoledronic acid and denosumab prevent bone fractures among men with...

$885K
USD
Completed NON-SBIR/STTR RPGS
Roles of Coactivator-Associated Arginine Methyltransferase 1 in B cell activation and lymphomagenesis
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

PROJECT SUMMARY Follicular lymphoma (FL) and diffuse large B cell lymphoma (DLBCL) are the most common germinal center (GC)- derived Non-Hodgkin B cell lymphomas (BCLs).Although in...

$4.53M
USD
Completed NON-SBIR/STTR RPGS
Harnessing Rare Variants for Tumor Classification
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2024

Abstract This project concerns how to extract clinically actionable information for diagnostic purposes from mutational patterns observed from tumor sequencing panels that are incr...

$4.05M
USD
Completed NON-SBIR/STTR RPGS
Analyzing the Hypersensitivity of MMR-deficient Colorectal Cancers to mTOR Inhibition and the Response of Cancer Stem Cells
NATIONAL CANCER INSTITUTE Albert Einstein College of Medicine United States 2021 – 2026

Project Summary Mutations in DNA mismatch repair (MMR) genes are causative in Lynch Syndrome (LS) and defective MMR drives tumorigenesis in a significant proportion (15 - 20%) of s...

$4.22M
USD
Completed TRAINING, INDIVIDUAL
Mechanisms of tumor microenvironmental regulation of T-cell infiltration in melanoma
NATIONAL CANCER INSTITUTE Harvard Medical School United States 2021 – 2024

Project Summary Melanoma is the deadliest form of skin cancer, with over 100,000 new cases and 6,000 deaths predicted in the United States in 2020.While the advent of immune checkp...

$395.5K
USD
Completed OTHER RESEARCH-RELATED
Targeting the IL-33/ST2 Pathway in Colorectal Cancer Immunotherapy
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2023

Summary/Abstract: I am a postdoctoral fellow at Indiana University who has developed a unique set of skills in tumor immunology and cancer immunotherapy.Throughout my graduate and...

$1.19M
USD
Completed OTHER RESEARCH-RELATED
Behavioral Activation for Depression in Older Adult Cancer Survivors: Pilot Randomized Control Trial and Implementation Outcomes
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

Project Summary/Abstract: As many as 35% of older adult cancer survivors (OACS; ?65-years, ?1-year post- treatment) have clinically significant depression. Presently, 64% of cancer...

$1.75M
USD
Completed OTHER RESEARCH-RELATED
Investigating Transcriptional Elongation and Nuclear RNA Surveillance in Melanoma
NATIONAL CANCER INSTITUTE Boston Children'S Hospital United States 2021 – 2021

Project Summary Metastatic melanoma, a cancer derived from pigment-producing melanocytes, is the deadliest type of skin cancer. Metastatic melanoma that is refractory or resistant...

$595.2K
USD
Completed TRAINING, INDIVIDUAL
Mindfulness and Cognitive Behavioral Therapy for Sleep in Cancer
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2024

Hematologic cancer patients are at high risk for developing insomnia and daytime fatigue, pain, and distress in the months after inpatient treatment.Extended hospitalization for ch...

$656.1K
USD
Completed OTHER RESEARCH-RELATED
Function of mesothelial cells in the tumor microenvironment of pancreatic ductal adenocarcinoma
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2023

Project Summary/Abstract Pancreatic ductal adenocarcinoma (PDA) is a lethal disease characterized by extensive desmoplasia caused by the rapid expansion of cancer-associated fibrob...

$1.16M
USD
Completed OTHER RESEARCH-RELATED
Can a subset of patients with HER2+ metastatic breast cancer be cured?
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

PROJECT SUMMARY Because of the development of highly effective HER2-targeted therapies over the past two decades, most patients now diagnosed with stage I-III HER2+ breast cancer (...

$2.59M
USD
Completed TRAINING, INDIVIDUAL
TRANSCRIPTIONAL REPROGRAMMING OF ESR1 MUTANT BREAST CANCER IN METASTASIS AND TREATMENT RESISTANCE
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2024

Project Summary Up to 1 in 8 women in the United States will develop invasive breast cancer in their lifetime, with 70-80% of cases being estrogen receptor positive (ER+).These can...

$460.4K
USD
Completed TRAINING, INDIVIDUAL
Targeting the Oncogenic Fusion Transcription Factor PAX3-FOXO1 with Small Molecules
NATIONAL CANCER INSTITUTE Massachusetts Institute of Technology United States 2021 – 2024

PROJECT SUMMARY Fusion transcription factors (TFs) are an enticing class of cancer targets.When present in a malignancy, these chimeric proteins are often the primary oncogenic dri...

$656.1K
USD
Completed NON-SBIR/STTR RPGS
Federal School Nutrition Policies, Student Food Insecurity and BMI
NATIONAL CANCER INSTITUTE Rand Corporation United States 2021 – 2022

Project Abstract Food insecurity increased since COVID-19 and children who are food insecure are at increased risk of physical and mental health disorders.In response to pandemic-r...

$1M
USD
Completed SBIR-STTR RPGS
Optimizing Radiosynthetic Yield of [18F]FTT For Wide-Spread Distribution
NATIONAL CANCER INSTITUTE Trevarx Biomedical, Inc United States 2021 – 2022

ABSTRACT: Poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi?s) have emerged as important new therapeutic agents targeting a broadening class of gene mutations present in breast...

$3.9M
USD